|
OMIM |
Link |
Information gain |
01 |
|
collagenosis, familial reactive perforating
|
[NCBI]
|
0.00572149
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.00143026
|
|
|
SLE
|
[NCBI]
|
0.00135799
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.000705355
|
|
|
MVP
|
[NCBI]
|
0.000398025
|
|
|
COL2A1
|
[NCBI]
|
0.00036355
|
|
|
cardiomyopathy-hypogonadism-collagenoma syndrome
|
[NCBI]
|
0.000282396
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
0.000279791
|
|
|
RA
|
[NCBI]
|
0.000184409
|
|
|
EPS
|
[NCBI]
|
0.000177219
|
|
|
ehlers-danlos syndrome, type vii, autosomal dominant
|
[NCBI]
|
0.000125013
|
|
|
COL1A1
|
[NCBI]
|
0.000119773
|
|
|
heart block, congenital
|
[NCBI]
|
0.000109179
|
|
|
alpha-2-deficient collagen disease
|
[NCBI]
|
0.000106151
|
|
|
ehlers-danlos syndrome, beasley-cohen type
|
[NCBI]
|
0.000106151
|
|
|
HFTC
|
[NCBI]
|
9.2882e-05
|
|
|
SEDC
|
[NCBI]
|
8.71069e-05
|
|
|
fascial dystrophy, congenital
|
[NCBI]
|
8.37014e-05
|
|
|
COL1A2
|
[NCBI]
|
7.61166e-05
|
|
|
larsen-like syndrome, lethal type
|
[NCBI]
|
7.52424e-05
|
|
|
spondylometaphyseal dysplasia with dentinogenesis imperfecta
|
[NCBI]
|
7.52424e-05
|
|
|
FCGRT
|
[NCBI]
|
6.51968e-05
|
|
|
hyalinosis, infantile systemic
|
[NCBI]
|
6.24434e-05
|
|
|
marfanoid hypermobility syndrome
|
[NCBI]
|
6.24434e-05
|
|
|
TROVE2
|
[NCBI]
|
6.18211e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
6.07362e-05
|
|
|
melorheostosis
|
[NCBI]
|
5.74516e-05
|
|
|
PVOD
|
[NCBI]
|
5.54431e-05
|
|
|
winchester syndrome
|
[NCBI]
|
5.54431e-05
|
|
|
COL6A2
|
[NCBI]
|
4.99813e-05
|
|
|
kniest dysplasia
|
[NCBI]
|
4.69181e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
4.58597e-05
|
|
|
DCN
|
[NCBI]
|
4.52677e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
4.4869e-05
|
|
|
PLOD1
|
[NCBI]
|
4.33297e-05
|
|
|
buschke-ollendorff syndrome
|
[NCBI]
|
4.22297e-05
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
4.1442e-05
|
|
|
COL10A1
|
[NCBI]
|
4.13449e-05
|
|
|
UCMD
|
[NCBI]
|
3.92971e-05
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
3.86447e-05
|
|
|
COL7A1
|
[NCBI]
|
3.6595e-05
|
|
|
DMPK
|
[NCBI]
|
3.61621e-05
|
|
|
COL3A1
|
[NCBI]
|
3.55467e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
3.20447e-05
|
|
|
STL1
|
[NCBI]
|
3.16412e-05
|
|
|
PXE
|
[NCBI]
|
3.15563e-05
|
|
|
VIM
|
[NCBI]
|
3.10223e-05
|
|
|
BTK
|
[NCBI]
|
2.91086e-05
|
|
|
CFH
|
[NCBI]
|
2.89067e-05
|
|
|
MEN1
|
[NCBI]
|
2.68486e-05
|
|
|
LSA
|
[NCBI]
|
2.29957e-05
|
|
|
HGF
|
[NCBI]
|
1.98873e-05
|
|
|
HP
|
[NCBI]
|
1.7741e-05
|
|
|
ALB
|
[NCBI]
|
1.61238e-05
|
|
|
ACH
|
[NCBI]
|
1.50446e-05
|
|
|
BCNS
|
[NCBI]
|
1.05775e-05
|
|
|
ADA
|
[NCBI]
|
9.31392e-06
|
|
|
RNASE3
|
[NCBI]
|
8.87998e-06
|
|
|
CAT
|
[NCBI]
|
6.5585e-06
|
|
|
MFS
|
[NCBI]
|
6.15587e-06
|
|
|
AVP
|
[NCBI]
|
3.62589e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.1083e-06
|
|
|
VEGF
|
[NCBI]
|
1.50931e-06
|
|
|
PRL
|
[NCBI]
|
1.2807e-06
|
|
|
TNF
|
[NCBI]
|
9.36158e-07
|
|
|
MG
|
[NCBI]
|
2.06641e-07
|
|